CAS RN: 158261-95-1
3-(1-PYRROLIDINYL)-1-BUTANOL
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250610
100mg / 250mg / 1g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 158261-95-1
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shanghai
Inquiry
158261-95-1 / 3-pyrrolidin-1-ylbutan-1-ol
Standard CAS: 158261-95-1
Multi CAS: No
Basic Information
copy
CAS
158261-95-1 copy
Multi CAS
No copy
Molecular Formula
C8H17NO copy
Molecular Weight
143.230000 copy
Exact Mass
143.131014 copy
SMILES
CC(CCO)N1CCCC1 copy
InChI
InChI=1S/C8H17NO/c1-8(4-7-10)9-5-2-3-6-9/h8,10H,2-7H2,1H3 copy
InChIKey
FKCMGWYAPOCAKE-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
10 copy
Fraction Csp3
1 copy
Rotatable bonds
3 copy
H-bond acceptors
2 copy
H-bond donors
1 copy
Molar refractivity
41.97 copy
TPSA
23.47 copy
LogP / Solubility
WLOGP
0.85 copy
MLOGP
0.74 copy
XLogP3
0.9 copy
Consensus LogP
0.83 copy
Log S (ESOL)
-1.07 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-1.35 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.66 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.99 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
2 copy